Back to 
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
ASND
Showing 7 of 21 quarters
Position history for Farallon Capital Management, L.L.C.'s holdings in Ascendis Pharma A/S
No. Farallon Capital Management exited its ASND (Ascendis Pharma) position in Q1 2026. Its Q4 2025 13F listed 1,400 shares worth $298,536. Farallon Capital Management already held ASND in its Q4 2018 13F, the earliest on record, and held it in 17 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$209,034
Total Shares Change
-1,400
Quarter-by-Quarter History